Combinations of oral blood glucose lowering drugs

• A10BD01: phenformin and sulfonylureas
• A10BD02: metformin and sulfonylureas
• A10BD03: metformin and rosiglitazone
• A10BD04: glimepiride and rosiglitazone
• A10BD05: metformin and pioglitazone
• A10BD06: glimepiride and pioglitazone
• A10BD07: metformin and sitagliptin
• A10BD08: metformin and vildagliptin
• A10BD09: pioglitazone and alogliptin
• A10BD10: metformin and saxagliptin
• A10BD11: metformin and linagliptin
• A10BD12: pioglitazone and sitagliptin
• A10BD13: metformin and alogliptin
• A10BD14: metformin and repaglinide
• A10BD15: metformin and dapagliflozin
• A10BD16: metformin and canagliflozin
• A10BD17: metformin and acarbose
• A10BD18: metformin and gemigliptin
• A10BD19: linagliptin and empagliflozin

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Combinations of oral blood glucose lowering drugs/adverse effects"[Mesh] OR "Combinations of oral blood glucose lowering drugs/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])